A Phase II study of iodine-131 tositumomab plus chemotherapy in patients with previously untreated mantle cell lymphoma
Saved in:
| Published in | Clinical lymphoma, myeloma and leukemia Vol. 20; no. 11; pp. 749 - 756.e1 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
29.04.2019
|
| Online Access | Get full text |
Cover
Loading…
| Author | Noy, Ariela Lin, Thomas S. Divgi, Chaitanya R. Donnelly, Gerard Sgouros, George Rijo, Ivelise Popplewell, Leslie L. Zelenetz, Andrew D. Horner, Thierry J. |
|---|---|
| AuthorAffiliation | a Memorial Sloan-Kettering Cancer Center, Division of Hematologic Oncology, Lymphoma Service, New York, NY, USA b City of Hope Medical Center, Duarte, CA, USA g Columbia University, New York, NY, USA e North Shore University Hospital, New York, NY, USA f Johns Hopkins Hospital, Baltimore, MD, USA c Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill-Cornell Medical Center, New York, NY, USA d GlaxoSmithKline, Oncology Research and Development, Collegeville, PA, USA |
| AuthorAffiliation_xml | – name: a Memorial Sloan-Kettering Cancer Center, Division of Hematologic Oncology, Lymphoma Service, New York, NY, USA – name: b City of Hope Medical Center, Duarte, CA, USA – name: d GlaxoSmithKline, Oncology Research and Development, Collegeville, PA, USA – name: e North Shore University Hospital, New York, NY, USA – name: f Johns Hopkins Hospital, Baltimore, MD, USA – name: c Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill-Cornell Medical Center, New York, NY, USA – name: g Columbia University, New York, NY, USA |
| Author_xml | – sequence: 1 givenname: Andrew D. surname: Zelenetz fullname: Zelenetz, Andrew D. organization: Memorial Sloan-Kettering Cancer Center, Division of Hematologic Oncology, Lymphoma Service, New York, NY, USA City of Hope Medical Center, Duarte, CA, USA Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill-Cornell Medical Center, New York, NY, USA GlaxoSmithKline, Oncology Research and Development, Collegeville, PA, USA North Shore University Hospital, New York, NY, USA Johns Hopkins Hospital, Baltimore, MD, USA Columbia University, New York, NY, USA – sequence: 2 givenname: Leslie L. surname: Popplewell fullname: Popplewell, Leslie L. organization: Memorial Sloan-Kettering Cancer Center, Division of Hematologic Oncology, Lymphoma Service, New York, NY, USA City of Hope Medical Center, Duarte, CA, USA Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill-Cornell Medical Center, New York, NY, USA GlaxoSmithKline, Oncology Research and Development, Collegeville, PA, USA North Shore University Hospital, New York, NY, USA Johns Hopkins Hospital, Baltimore, MD, USA Columbia University, New York, NY, USA – sequence: 3 givenname: Ariela surname: Noy fullname: Noy, Ariela organization: Memorial Sloan-Kettering Cancer Center, Division of Hematologic Oncology, Lymphoma Service, New York, NY, USA City of Hope Medical Center, Duarte, CA, USA Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill-Cornell Medical Center, New York, NY, USA GlaxoSmithKline, Oncology Research and Development, Collegeville, PA, USA North Shore University Hospital, New York, NY, USA Johns Hopkins Hospital, Baltimore, MD, USA Columbia University, New York, NY, USA – sequence: 4 givenname: Thierry J. surname: Horner fullname: Horner, Thierry J. organization: Memorial Sloan-Kettering Cancer Center, Division of Hematologic Oncology, Lymphoma Service, New York, NY, USA City of Hope Medical Center, Duarte, CA, USA Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill-Cornell Medical Center, New York, NY, USA GlaxoSmithKline, Oncology Research and Development, Collegeville, PA, USA North Shore University Hospital, New York, NY, USA Johns Hopkins Hospital, Baltimore, MD, USA Columbia University, New York, NY, USA – sequence: 5 givenname: Thomas S. surname: Lin fullname: Lin, Thomas S. organization: Memorial Sloan-Kettering Cancer Center, Division of Hematologic Oncology, Lymphoma Service, New York, NY, USA City of Hope Medical Center, Duarte, CA, USA Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill-Cornell Medical Center, New York, NY, USA GlaxoSmithKline, Oncology Research and Development, Collegeville, PA, USA North Shore University Hospital, New York, NY, USA Johns Hopkins Hospital, Baltimore, MD, USA Columbia University, New York, NY, USA – sequence: 6 givenname: Gerard surname: Donnelly fullname: Donnelly, Gerard organization: Memorial Sloan-Kettering Cancer Center, Division of Hematologic Oncology, Lymphoma Service, New York, NY, USA City of Hope Medical Center, Duarte, CA, USA Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill-Cornell Medical Center, New York, NY, USA GlaxoSmithKline, Oncology Research and Development, Collegeville, PA, USA North Shore University Hospital, New York, NY, USA Johns Hopkins Hospital, Baltimore, MD, USA Columbia University, New York, NY, USA – sequence: 7 givenname: George surname: Sgouros fullname: Sgouros, George organization: Memorial Sloan-Kettering Cancer Center, Division of Hematologic Oncology, Lymphoma Service, New York, NY, USA City of Hope Medical Center, Duarte, CA, USA Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill-Cornell Medical Center, New York, NY, USA GlaxoSmithKline, Oncology Research and Development, Collegeville, PA, USA North Shore University Hospital, New York, NY, USA Johns Hopkins Hospital, Baltimore, MD, USA Columbia University, New York, NY, USA – sequence: 8 givenname: Ivelise surname: Rijo fullname: Rijo, Ivelise organization: Memorial Sloan-Kettering Cancer Center, Division of Hematologic Oncology, Lymphoma Service, New York, NY, USA City of Hope Medical Center, Duarte, CA, USA Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill-Cornell Medical Center, New York, NY, USA GlaxoSmithKline, Oncology Research and Development, Collegeville, PA, USA North Shore University Hospital, New York, NY, USA Johns Hopkins Hospital, Baltimore, MD, USA Columbia University, New York, NY, USA – sequence: 9 givenname: Chaitanya R. surname: Divgi fullname: Divgi, Chaitanya R. organization: Memorial Sloan-Kettering Cancer Center, Division of Hematologic Oncology, Lymphoma Service, New York, NY, USA City of Hope Medical Center, Duarte, CA, USA Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill-Cornell Medical Center, New York, NY, USA GlaxoSmithKline, Oncology Research and Development, Collegeville, PA, USA North Shore University Hospital, New York, NY, USA Johns Hopkins Hospital, Baltimore, MD, USA Columbia University, New York, NY, USA |
| BookMark | eNqlzM1Kw0AUBeBBKrZVX8DVfYHGOxMTm5WIKHbnwn2YJrfOlPljflry9mYhgmtX58A5fGu2cN4RY3ccK468vT9Wg7GmEsi7Ch8q5HjBVoI3YiPatlv89gaXbJ3SEfER5-8VW9Zii9jw7Yqdn-FDyUSw20HKZZzAH0D7UTva8JpD9knnYr2VewimJBgUWZ8VRRkm0A6CzJpcTnDWWUGIdNK-JDNBcTmSzDSClS4bgoGMATPZoGbthl0epEl0-5PX7Ont9fPlfRPK3tI4zGSUpg9RWxmn3kvd_12cVv2XP_UcW9HVraj_L3wDTAZv9g |
| ContentType | Journal Article |
| DBID | 5PM |
| DOI | 10.1016/j.clml.2019.04.010 |
| DatabaseName | PubMed Central (Full Participant titles) |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2152-2669 |
| EndPage | 756.e1 |
| GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1P~ 1~. 4.4 457 4G. 53G 5PM 5VS 6PF 7-5 8P~ AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAWTL AAXKI AAXUO ABBQC ABMAC ABMZM ACDAQ ACGFS ACRLP ADBBV ADEZE AEBSH AEKER AENEX AEVXI AFCTW AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV C45 DU5 EBS EFJIC EJD EMB EMOBN F5P FDB FEDTE FIRID FNPLU FYGXN GBLVA HVGLF KOM M41 MO0 O-L O9- OAUVE OC~ OO- OVD P-8 P-9 PC. Q38 ROL SDF SEL SES SPCBC SSH SSZ T5K TEORI XH2 Z5R ~G- |
| ID | FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_106293623 |
| ISSN | 2152-2650 |
| IngestDate | Tue Sep 17 21:29:30 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-pubmedcentral_primary_oai_pubmedcentral_nih_gov_106293623 |
| Notes | ADZ was the Principle Investigator, designed the study and protocol, contributed to data collection, analysis and interpretation. AN, CRD, GS, GD, IR, and LLP contributed to protocol development and data acquisition. TJH, and TSL contributed to the study design and data analysis and interpretation. All authors were involved at each stage of manuscript preparation and approved the final version. Current affiliation: Janssen, Scientific Affairs, Horsham, PA, USA Current affiliation: NYU Perlmutter Cancer Center, Lake Success, NY, USA Author contributions |
| PMID | 32800518 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10629362 |
| PublicationCentury | 2000 |
| PublicationDate | 20190429 |
| PublicationDateYYYYMMDD | 2019-04-29 |
| PublicationDate_xml | – month: 4 year: 2019 text: 20190429 day: 29 |
| PublicationDecade | 2010 |
| PublicationTitle | Clinical lymphoma, myeloma and leukemia |
| PublicationYear | 2019 |
| SSID | ssj0070019 |
| Score | 4.4379973 |
| SourceID | pubmedcentral |
| SourceType | Open Access Repository |
| StartPage | 749 |
| Title | A Phase II study of iodine-131 tositumomab plus chemotherapy in patients with previously untreated mantle cell lymphoma |
| URI | https://pubmed.ncbi.nlm.nih.gov/PMC10629362 |
| Volume | 20 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF6MAyGX0id9s4feFgmvXrZORaQtVhubHFwIvQRLGRE3epjYorj_r_-rM_uQlZBD64sQu1iSdz5mZne_-ZaxD-M8C8IsyJ24yCMnCJbSif2scAIosvjKLwI5onrn2Tyafg--XoQXg8GfHmup3WZu_vvBupJDrIptaFeqkv0Py3YPxQa8R_viFS2M13-ycSLOrzEKiTTVMrFK_6HBaASO9CWmlZvVtq2aapmJddluBBqoMhVXqtzPiKqaCrc1MX6bdlPuRFsrAjomoxWOfAmC1vdFuUPTN8aRW3UDW1lpO8lm1Q5KvFUbEyW0N1CtOu__g-IcqFNkDZtSfHI7B91gUgyWqH0GmASDOOu653rhMMHpfdk9cNrcmqKdBZ3rTSRAt7-WIdW2jFnwUC6PDtl1vEhL0brQb9MHulif7Y362JQ9DzzWCqgmmI_DyAX5YKjQqxY_3bysaAtKxkryVnNse9hZVwo8vjch_zXZh01LFTifneK0GrMmygSOvHEchkN2lKTfpnObEtDePs3Dur9nqrc00fD-B5ywY_u2-0zdXuqzeMwemTkLTzQAn7AB1E_Z8cywMp6xXwlXOORpyhUOeVPwPQ55D4eccMj7OOSrmlsccsIh3-OQdzjkGoeccMgt1J6zj18-L06nzp2vv1xrAZVLkjS_21OvrpW0uR1J_wUb1k0NLxmPR1B4JCgigyyI4mWcYU4ewSi_Ahw0mLxik0Pf8vrwn75hJ3sAv2XD7W0L7zA93WbvjfH_AgJLnmc |
| link.rule.ids | 230,315,786,790,891,27955,27956 |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Phase+II+study+of+iodine-131+tositumomab+plus+chemotherapy+in+patients+with+previously+untreated+mantle+cell+lymphoma&rft.jtitle=Clinical+lymphoma%2C+myeloma+and+leukemia&rft.au=Zelenetz%2C+Andrew+D.&rft.au=Popplewell%2C+Leslie+L.&rft.au=Noy%2C+Ariela&rft.au=Horner%2C+Thierry+J.&rft.date=2019-04-29&rft.issn=2152-2650&rft.eissn=2152-2669&rft.volume=20&rft.issue=11&rft.spage=749&rft.epage=756.e1&rft_id=info:doi/10.1016%2Fj.clml.2019.04.010&rft_id=info%3Apmid%2F32800518&rft.externalDBID=PMC10629362 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2152-2650&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2152-2650&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2152-2650&client=summon |